Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 12.39B | 12.18B | 11.02B | 9.94B | 10.81B | 9.84B | 9.09B |
| Cost of revenue | — | — | — | — | 6.76B | 6.23B | 5.57B |
| Research and development | 440M | 415M | 359M | 359M | — | 331M | 300M |
| Selling, general and administrative | 1.08B | 1.20B | 1.02B | 876M | — | 1.33B | 924M |
| Operating expenses | 10.18B | 9.95B | 8.93B | 7.99B | — | 8.97B | 7.58B |
| Pre-tax income | 2.20B | 2.52B | 2.39B | 2.25B | — | 1.89B | 1.45B |
| Income tax | 252M | 344M | 388M | 283M | — | 198M | 125M |
| Net income | 1.90B | 2.16B | 2.03B | 1.98B | 1.90B | 1.85B | 1.27B |
| Earnings per share | 1.82 | 2.04 | 1.91 | 1.85 | 1.76 | 1.71 | 1.16 |
| Earnings per share, diluted | 1.81 | 2.02 | 1.89 | 1.83 | 1.75 | 1.70 | 1.15 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 10.98B | 12.39B | 12.50B | 10.86B | 12.41B | 13.62B | 13.72B | 12.11B |
| Receivables | 12.47B | 11.77B | 10.67B |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.82B | — | — | 1.51B | — | — |
| Depreciation and amortisation | 227M | 214M | 219M | 210M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 10.51B |
| 9.65B |
| 9.33B |
| 8.94B |
| 8.37B |
| Inventory | 12.37B | 11.87B | 11.67B | 11.30B | 10.50B | 9.76B | 9.72B | 9.47B |
| Current assets | 40.36B | 40.60B | 40.07B | 37.80B | 37.58B | 37.64B | 38.65B | 37.35B |
| Goodwill | 9.00B | 9.06B | 9.04B | 9.01B | 8.70B | 8.54B | 8.75B | 8.86B |
| Total assets | 128.45B | 130.17B | 128.24B | 125.26B | 124.12B | 123.14B | 126.70B | 123.19B |
| Current liabilities | 40.03B | 38.98B | 37.20B | 36.47B | 34.94B | 34.39B | 34.09B | 32.75B |
| Short-term debt | 2.10B | 1.69B | 2.07B | 1.89B | 2.08B | 2.04B | 1.68B | 1.70B |
| Long-term debt | 18.17B | 18.81B | 18.77B | 17.00B | 17.49B | 17.23B | 18.24B | 17.97B |
| Total liabilities | 110.15B | 111.27B | 109.22B | 105.91B | 104.65B | 103.58B | 107.60B | 104.35B |
| Equity | 18.06B | 18.68B | 18.81B | 19.14B | 19.25B | 19.34B | 19.10B | 18.84B |
| Shares outstanding | 1.04B | 1.05B | 1.05B | 1.06B | 1.07B | 1.07B | 1.08B | 1.08B |
| Shares issued | — | 1.46B | — | — | — | — | — | — |
| 224M |
| 199M |
| Capital expenditure | 331M | — | — | 208M | — | — |
| Investing cash flow | −919M | — | — | −317M | — | — |
| Share buybacks | 2.40B | — | — | 1.97B | — | — |
| Financing cash flow | −2.83B | — | — | −2.28B | — | — |